BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference Ready to Announce with Confidence?
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 29, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will present at the upcoming Canaccord Genuity 46th Annual Growth Conference, to be held on August 11-13, 2026, in Boston, Massachusetts. In addition to presenting, Dr. Rakib will also be participating in one-on-one investor meetings from August 11-12.
Presentation Details:
The live online webcast is publicly accessible for all online pre-registrants, and registration is mandatory for in-person conference participation. Investors attending the conference may request a one-on-one meeting with BioHarvest Sciences through their Canaccord Genuity representative.
Canaccord Genuity's 46th Annual Growth Conference aims to bring together institutional investors from across the globe with some of the best and most promising growth companies in the Technology, Healthcare & Life Sciences, Sustainability, Industrials, and Consumer & Retail sectors. For more information, please visit the conference website.
About BioHarvest
BioHarvest (NASDAQ: BHST) (FSE: 8MV0) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products based on its botanical synthesis technology. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws. These statements are based on management's current expectations, beliefs, and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by applicable law. Additional information is contained in the Company's SEC filings, available at http://www.sec.gov.
BioHarvest Company Contact
Dave Ryan, VP Investor Relations
(604) 622-1186 | info@bioharvest.com
Investor Relations Contact:
Chuck Padala, Managing Director
LifeSci Advisors
chuck@lifesciadvisors.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/307087
Source: BioHarvest Sciences Inc.
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for BioHarvest Sciences Inc. or all companies in the Health, Biotechnology, Pharmaceuticals industry.
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
2026-07-29 8:00 AM EDT
BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026
2026-07-28 8:00 AM EDT
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
2026-07-15 7:30 AM EDT
Apr 27, 2026
For global mining companies, disclosure does not happen in a single market or a single time zone. It is continuous, time-sensitive, and often coordinated across continents. Adyton Resources is a TSX Venture-listed exploration company operating in Papua New Guinea, with its team based in Australia. In this environment, disclosure is not just about generating information. It is about executing it with precise timing and coordination across time zones. “The ability to file 24/7 with immediate...
Economy, Business and Finance
Biotechnology
Chemicals
Pharmaceutical
Health
Science and Technology
Health
Biotechnology
Pharmaceuticals